| # | Drug | Count |
|---|---|---|
| 0 | LANSOPRAZOLE | 12 |
| 1 | ESOMEPRAZOLE | 11 |
| 2 | ESOMEPRAZOLE MAGNESIUM | 11 |
| 3 | RANITIDINE | 11 |
| 4 | EVOLOCUMAB | 2 |
| 5 | NIFEDIPINE | 2 |
| 6 | SECUKINUMAB | 2 |
| 7 | ADALIMUMAB | 1 |
| 8 | ALBUTEROL | 1 |
| 9 | ALBUTEROL SULFATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUERCETIN | 1 | 0.0008 |
| 1 | FLUVASTATIN SODIUM | 1 | 0.0002 |
| 2 | DEGARELIX | 1 | 0.0002 |
| 3 | IOHEXOL | 1 | 0.0001 |
| 4 | ENTECAVIR | 1 | 0.0001 |
| 5 | LANSOPRAZOLE | 12 | 0.0001 |
| 6 | ISONIAZID | 1 | 0.0001 |
| 7 | RANITIDINE | 11 | 0.0001 |
| 8 | NIFEDIPINE | 2 | 0.0000 |
| 9 | ESOMEPRAZOLE MAGNESIUM | 11 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 12 |
| 1 | Dihydropyridine Calcium Channel Blocker [EPC] | 3 |
| 2 | Interleukin-17A Antagonist [EPC] | 2 |
| 3 | PCSK9 Inhibitor [EPC] | 2 |
| 4 | Vitamin C [EPC] | 2 |
| 5 | Alkylating Drug [EPC] | 1 |
| 6 | Antimycobacterial [EPC] | 1 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 1 |
| 8 | Calcium Channel Blocker [EPC] | 1 |
| 9 | Corticosteroid [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 2 | 0.0001 |
| 1 | Interleukin-17A Antagonist [EPC] | 2 | 0.0001 |
| 2 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 3 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Radiographic Contrast Agent [EPC] | 1 | 0.0000 |
| 5 | Leukotriene Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 7 | Proton Pump Inhibitor [EPC] | 12 | 0.0000 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Potassium Channel Blocker [EPC] | 1 | 0.0000 |